Pannacean

Pannacean focuses on the research and development of APIs, drug substances, drug metabolites and related substances (impurities), key intermediates and a variety of new and novel nucleosides and phosphoramidite monomers for various oligonucleotide and RNA syntheses. Pannacean is an innovative R&D enterprise on high technologies. The highly experienced executive teams at Pannacean established long-term enriched and hands-on experiences on the broad medicine related fields. Substantial achievements on the successful IND and NDA approvals demonstrated their highly efficient project managing and leading capacity. Our well-established and strong R&D capacity solved all kinds of challenges for our cooperative partners, and accelerated our partners’ success by providing highly reliable services on new drug discovery and development of small and bio-molecules as well as biotechnologies. Pannacean promises the world-class products, technologies and services.